24MAY

Mpox strain mixes genes from two clades

2 min read

16:06UTC

WHO reported a recombinant mpox virus carrying genetic elements from both clade Ib and clade IIb, now found in four countries, with transmissibility still unknown.

← Back to Ebola triples, response misfires Jump to analysis ↓

ScienceDeveloping

Key takeaway

A recombinant mpox strain is a surveillance signal to track, not evidence of a more dangerous virus.

WHO's Disease Outbreak News 595 reported a recombinant mpox virus (MPXV) carrying genetic elements from both clade Ib and clade IIb ¹. It was first found in a UK traveller in December 2025 and identified retrospectively in India from September 2025, and now spans at least four countries across three WHO regions ². Mpox, formerly monkeypox, circulates in distinct lineages called clades; a recombinant carries DNA from two of them at once.

Recombination happens when two virus lineages co-infect a single host and swap genetic material. It is expected wherever clades circulate together, and detecting it is the reason genomic surveillance exists rather than evidence that surveillance has failed. The strain's appearance on the record is the system working: routine sequencing flagged a hybrid and traced it back through stored samples to September 2025. This is the kind of early signal WHO's R&D Blueprint pathogen-prioritisation programme exists to catch .

WHO calls it premature to draw any conclusion about transmissibility from so few cases, and reports no serious complications in the patients identified ³. A hybrid genome does not by itself imply a more dangerous virus, so this reads as a watch item rather than an alarm. Whether the recombinant spreads or sickens differently from its parent strains is a question only more sequencing can answer, and WHO says both sequencing and surveillance are being intensified ⁴.

Deep Analysis

In plain English

Mpox (formerly called monkeypox) is a virus that has two main family branches, called clades. Clade Ib has been driving an outbreak in central Africa with higher death rates in unvaccinated people. Clade IIb spread globally in 2022-2024, primarily through close physical contact, and is now widespread in many countries. Scientists have now found a version of the virus that appears to have mixed genetic material from both clades, a 'recombinant' strain. It was first spotted in a UK traveller in December 2025 and found retrospectively in India from September 2025. This is a watch item, not an alarm: the WHO found the recombinant strain in at least four countries across three regions, but reported no serious illness in identified patients and says it is too early to know if this strain spreads more easily than its parent versions. Sequencing (gene-reading of more samples) is being intensified to understand what, if anything, has changed.

Source Landscape

This story draws on neutral-leaning sources

Consensus view: The European Centre for Disease Prevention and Control (ECDC) assessed in its May 2026 monitoring review that the recombinant clade Ib/IIb MPXV strain's identification across four countries and three WHO regions within a retrospective window stretching to September 2025 suggests the variant has been circulating quietly for at least eight months without triggering elevated clinical signals; the absence of serious complications in identified patients is a genuine data point, not a bureaucratic reassurance, and WHO's description of transmissibility conclusions as premature is the correct epidemiological reading given sample sizes.

Counter-view: The Institut Pasteur's structural virology team has noted that recombination events between clade Ib and clade IIb MPXV are theoretically significant because the two clades differ substantially in their immune-evasion gene complement.

Clade IIb circulates globally in human sexual networks and has broad population exposure, while clade Ib has higher case-fatality in unvaccinated populations. A recombinant carrying clade Ib's virulence factors alongside clade IIb's transmission efficiency would represent a qualitatively different pathogen, but the current evidence does not indicate this combination has been achieved.

Key tension: Whether intensified sequencing will reveal that the recombinant variant is already geographically wider than four countries, or whether its quiet eight-month circulation without outbreak signal indicates genuine lower pathogenicity relative to both parent clades.

Sources:World Health Organization

Mentions:World Health Organization →recombinant MPXV →United Kingdom →India →ECDC →

First Reported In

Update #4 · Ebola triples, response misfires

World Health Organization· 24 May 2026

Read original →

Different Perspectives

European Union / ECDC

ECDC activated an EU Health Task Force, assessed European Bundibugyo import risk as very low, and flagged the recombinant clade Ib/IIb mpox strain in four countries as a surveillance watch item. Both calls reflect the same post-2024 IHR mandate: ECDC acts as a continental early-warning layer rather than waiting for WHO Disease Outbreak News guidance.

Ituri and South Kivu communities / DRC

Residents in South Kivu torched a treatment facility when response teams arrived, a signal of community trust deficit that a no-state-apparatus response cannot overcome before it can begin. In Ituri, four healthcare worker deaths at Mongbwalu General Referral Hospital in four days reflect the population's first line of care bearing the outbreak's worst nosocomial burden without species-specific equipment or treatment.

Uganda / Diana Atwine

Atwine confirmed two imported Bundibugyo cases in Kampala with no onward spread, deployed a mobile laboratory to Kasese on the DRC border, and placed 25 contacts under monitoring before any IHR Temporary Recommendations existed. Uganda's response demonstrates that containment is achievable where a functioning state health authority can compel and protect.

Africa CDC / Jean Kaseya

Kaseya declared a continental emergency 24 hours before the WHO PHEIC and publicly opposed the US entry ban on 19 May, arguing it punishes countries by passport rather than exposure history. The declaration, Africa CDC's second consecutive pre-WHO move after the 2024 mpox sequencing, reflects an AU strategy to lead early-phase responses independently of Geneva.

United States / HHS

Washington imposed a 21-day entry ban on nationals of DRC, Uganda and South Sudan on 18 May, including green-card holders, and began enhanced screening for US citizens at George Bush Intercontinental Airport in Houston from 26 May. The ban predated WHO Temporary Recommendations by four days and covered South Sudan despite zero confirmed cases there.

Tedros Adhanom Ghebreyesus / WHO

Tedros declared the PHEIC on 17 May without the IHR Emergency Committee, then watched the committee's 22 May no-travel-restriction advice arrive four days after the US ban it was meant to prevent. A declaration without operational instructions left states parties with the headline of a global emergency but no guidance on screening, trade or deployment.